Abstract
BackgroundIn recent years, researchers have had an increased focus on multiplex microarray assays, in which antibodies are measured against multiple related antigens, for use in seroepidemiological studies to infer past transmission. MethodsWe assess the performance of a flavivirus microarray assay for determining past dengue virus (DENV) infection history in a dengue-endemic setting, Vietnam. We tested the microarray on samples from 1 and 6 months postinfection from DENV-infected patients (infecting serotype was determined using reverse-transcription polymerase chain reaction during acute, past primary, and secondary infection assessed using plaque reduction neutralization tests 6 months postinfection). ResultsBinomial models developed to discriminate past primary from secondary infection using the protein microarray (PMA) titers had high area under the curve (0.90–0.97) and accuracy (0.84–0.86). Multinomial models developed to identify most recent past infecting serotype using PMA titers performed well in those with past primary infection (average test set: κ = 0.85, accuracy of 0.92) but not those with past secondary infection (κ = 0.24, accuracy of 0.45). ConclusionsOur results suggest that the microarray will be useful in seroepidemiological studies aimed at classifying the past infection history of individuals (past primary vs secondary and serotype of past primary infections) and thus inferring past transmission intensity of DENV in dengue-endemic settings. Future work to validate these models should be undertaken in different transmission settings and with samples later after infection.
Highlights
In recent years, researchers have had an increased focus on multiplex microarray assays, in which antibodies are measured against multiple related antigens, for use in seroepidemiological studies to infer past transmission
Our results suggest that the microarray will be useful in seroepidemiological studies aimed at classifying the past infection history of individuals and inferring past transmission intensity of dengue virus (DENV) in dengue-endemic settings
In Vietnam, dengue is endemic, especially in the southern areas, with 1.50–2.75 million symptomatic infections estimated per year [2]
Summary
We assess the performance of a flavivirus microarray assay for determining past dengue virus (DENV) infection history in a dengue-endemic setting, Vietnam. We tested the microarray on samples from 1 and 6 months postinfection from DENV-infected patients (infecting serotype was determined using reverse-transcription polymerase chain reaction during acute, past primary, and secondary infection assessed using plaque reduction neutralization tests 6 months postinfection). Individuals in whom DENV infection had been confirmed by reverse-transcription polymerase chain reaction (RT-PCR) as part of the initial study were approached, and those who agreed to participate provided additional blood samples at 2 time points after the acute infection: 2–4 weeks (follow-up 1) and 6 months (follow-up 2) [18]. To ensure that we had as much data as possible from each group (infecting serotype and immune status), this included all of the individuals infected by DENV3 and all primary infections with DENV2 and DENV4 (due to small numbers in these groups [18]) and a selection from the remaining groups to ensure all groups were represented. This study, and the initial acute illness studies, was approved by the ethics committee of the Hospital of Tropical Diseases HCMC
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.